{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:13Z","timestamp":1778760433736,"version":"3.51.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    The risk factors for mucositis in patients undergoing autologous hematopoietic stem cell transplantation (AHSCT) are complex and encompass conditioning regimens, patient demographics, and microbiological alterations. A comprehensive understanding of these factors is essential for the development of targeted interventions aimed at reducing the severity of mucositis and enhancing patient outcomes. This study sought to identify the risk factors associated with mucositis in patients undergoing AHSCT in the blood transplantation purification ward of the First Affiliated Hospital of Soochow University and to propose strategies for its prevention. A retrospective analysis was conducted on hematological patients (N\u2005=\u2005104) who developed mucositis following AHSCT in our transplantation purification ward between June 2021 and March 2024. Patients were categorized based on the severity of mucositis using grading systems from the World Health Organization or the Common Terminology Criteria for Adverse Events. Potential risk factors, including conditioning regimens, post-transplant infections, and other clinical variables, were evaluated using univariate and multivariate logistic regression analyses. Univariate analysis identified the BEAM conditioning regimen, comprising carmustine, etoposide, cytarabine, and melphalan (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03), along with post-transplant infections (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02), as significant risk factors for the onset of mucositis. Subsequent multivariate analysis corroborated the carmustine, etoposide, cyarabine, and melphalan (BEAM regimen) as an independent risk factor (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.01). Other variables, such as age, type of underlying disease, and duration of neutropenia, did not exhibit a significant association with the development of mucositis. In conclusion, the BEAM regimen and post-transplant infections markedly elevate the risk of mucositis in patients undergoing AHSCT. Early identification of individuals at high risk, optimization of conditioning regimens, rigorous infection control protocols, and proactive oral care interventions may reduce the incidence and severity of mucositis, thereby improving patient outcomes. Further prospective studies are warranted to validate these findings and refine preventive strategies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045944","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:01:08Z","timestamp":1764169268000},"page":"e45944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the culprits: A retrospective case-control study on risk factors of mucositis in autologous stem cell transplantation"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2449-8854","authenticated-orcid":false,"given":"Guixia","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Ping","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy.","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/OTT.S96899","article-title":"Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy.","volume":"9","author":"Kwon","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1080\/10428194.2019.1581932","article-title":"Complications and hospital costs during hematopoietic stem cell transplantation for non-Hodgkin lymphoma in the United States.","volume":"60","author":"Cho","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"eRW4007","DOI":"10.1590\/s1679-45082018rw4007","article-title":"Chemotherapy protocols and incidence of oral mucositis. An integrative review.","volume":"16","author":"Curra","year":"2018","journal-title":"Einstein (Sao Paulo)"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/cancers17162657","article-title":"Elevated likelihood of infectious complications related to oral mucositis after hematopoietic stem cell transplantation: a systematic review and meta-analysis of outcomes and risk factors.","volume":"17","author":"Eichhorn","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R7-20260514","first-page":"9141","article-title":"The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.","volume":"30","author":"Nakagaki","year":"2022","journal-title":"Support Care Cancer"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","article-title":"Management of oral mucositis in patients who have cancer.","volume":"52","author":"Lalla","year":"2008","journal-title":"Dent Clin North Am"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2009.12.015","article-title":"Sex steroids as inflammatory regulators.","volume":"120","author":"Gilliver","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1705494","article-title":"Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.","volume":"38","author":"Mori","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5737\/1181912x1512931","article-title":"Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation.","volume":"15","author":"Salvador","year":"2005","journal-title":"Can Oncol Nurs J"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bmt.1705118","article-title":"Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.","volume":"36","author":"Blijlevens","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"R14-20260514","first-page":"142","article-title":"Factors affecting the incidence and severity of oral mucositis following hematopoietic stem cell transplantation.","volume":"12","author":"Valeh","year":"2018","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.soncn.2007.05.005","article-title":"Prevention and management of oral mucositis in patients with cancer.","volume":"23","author":"Eilers","year":"2007","journal-title":"Semin Oncol Nurs"},{"key":"R16-20260514","first-page":"6317","article-title":"Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life.","volume":"30","author":"Guberti","year":"2022","journal-title":"Support Care Cancer"},{"key":"R17-20260514","first-page":"9341","article-title":"Nutrition support use and clinical outcomes in patients with multiple myeloma undergoing autologous stem cell transplant.","volume":"30","author":"Kuypers","year":"2022","journal-title":"Support Care Cancer"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0148607108330314","article-title":"Enteral nutrition practice recommendations.","volume":"33","author":"Bankhead","year":"2009","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients.","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:07:08Z","timestamp":1778756828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":18,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045944","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-07-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}